Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Income ETFs

BIOY vs XLSI: Dividend Yield & Total Return

Share
Share on XDownload as PDF

BIOY and XLSI both write options for income.

askIQ about this page

askIQ about BIOY and XLSI

Net assets on Nov 3, 2026: $1.5m for GraniteShares YieldBOOST Biotech ETF and $25m for State Street Consumer Staples Select Sector SPDR Premium Income ETF.

At a glance
26.1%
BIOY cash paid, since launch, May 5, 2026
12.5%
XLSI cash paid, 1 year
+5.4%
BIOY total return, since launch, May 5, 2026
+16.3%
XLSI total return, 1 year
BIOY · since launch to Nov 4, 2026 13.6 pts behind XBI
BIOY
+5.4%
XBI
+19.0%

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

26.1% as cash

13.6 pts behind XBI

Total return, distributions reinvested

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

13.6 pts behind XBI

26.1% of it arrived as cash. Total return, distributions reinvested. BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.
XLSI · 1 year to Nov 4, 2026 8 pts behind XLP
XLSI
+16.3%
XLP
+24.3%

8 pts behind XLP

XLSI over 1 year: paid 12.5%, price +2.7%, total +16.3%, XLP +24.3%, −8.0 pts. Data to Nov 4, 2026.

XLP

+24.3%

XLSI

+16.3%

12.5% of it arrived as cash

8 pts behind XLP

Total return, distributions reinvested

8 pts behind XLP

XLSI over 1 year: paid 12.5%, price +2.7%, total +16.3%, XLP +24.3%, −8.0 pts. Data to Nov 4, 2026.

XLP

+24.3%

XLSI

+16.3%

8 pts behind XLP

12.5% of it arrived as cash. Both charts share one scale, with zero at the line. XLSI over 1 year: paid 12.5%, price +2.7%, total +16.3%, XLP +24.3%, −8.0 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.

Pair scorecard

XLSI costs 0.83 points a year less; XLSI is 16.7 times larger.

Points (pts) are percentage points.

BIOY vs XLSI: Dividend Yield & Total Return
MeasureBIOYXLSI
Paid and earned
Total return, 1 yearnot published+16.3%
Price changefell 21.9% (since May 5, 2026)rose 2.7% (1 year)
Return of capital, issuer estimate96% of the Sep 22, 2026 payment100% of the Nov 5, 2026 payment
Against its benchmark
BenchmarkBiotech, measured through XBIState Street Consumer Staples Select Sector SPDR ETF, measured through XLP
Against its benchmark, same daysbehind by 13.6 ptsbehind by 8.0 pts
Cost and size
Expense ratio1.18%0.35%
Net assets, as of Nov 3, 2026$1.5m$25m
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, BIOY and XLSI hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 3, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BIOY XLSI
Only in one fund ↓
Only in BIOY
Only in XLSI
STATE STREET CONSUMER STAPLES 102.28%
STATE STREET CONSUMER STAPLES NOV26 93 CALL -0.02%
STATE STREET CONSUMER STAPLES NOV26 88.5 CALL -0.02%
STATE STREET CONSUMER STAPLES NOV26 91.5 CALL -0.02%
STATE STREET CONSUMER STAPLES NOV26 92 CALL -0.03%
STATE STREET CONSUMER STAPLES NOV26 90 CALL -0.04%
STATE STREET CONSUMER STAPLES NOV26 88 CALL -2.19%
Check overlap with more funds →

Side by side

BIOY GraniteShares YieldBOOST Biotech ETF · Synthetic covered call on XBI, paying weekly XLSI State Street Consumer Staples Select Sector SPDR Premium Income ETF · Covered call on XLP, paying monthly
Strategy synthetic covered call covered call
Benchmark Biotech (XBI) State Street Consumer Staples Select Sector SPDR ETF (XLP)
Pays weekly monthly
Payout rate, annualized 60.7% 10.8%
Expense ratio 1.18% 0.35%
Cash paid, 1 year 26.1% (since launch, May 5, 2026) 12.5%
Price change, 1 year −21.9% (since launch, May 5, 2026) +2.7%
Total return, 1 year +5.4% (since launch, May 5, 2026) +16.3%
Benchmark return, 1 year +19.0% (since launch, May 5, 2026) +24.3%
Ahead or behind −13.6 pts (since launch, May 5, 2026) −8.0 pts
Return of capital, latest estimate 96% 100%
Age 183 days 1.3 years
Net assets, as of Nov 3, 2026 $1.5m $25m

As of Nov 4, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.

Window by window

Window by window: BIOY vs XLSI: Dividend Yield & Total Return
Total returnCash paidAgainst the benchmark
WindowBIOYXLSIBIOYXLSIBIOYXLSI
3 months+6.9%+5.1%14.5%3.0%+2.9 pts−3.3 pts
6 months+4.4%+8.5%25.9%6.2%−11.3 pts−2.1 pts
1 year–+16.3%–12.5%–−8.1 pts
Since launchNot the same days: BIOY May 2026 · XLSI Jul 2025+5.4%+12.1%26.1%14.9%−13.7 pts−6.1 pts

– means no data for this window. Open this comparison in the app →

Alert

XLSI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BIOY

Over the period from its first trade on May 5, 2026 to Nov 4, 2026, BIOY paid 26.1% of its starting value in cash distributions while its price fell 21.9%. With every distribution reinvested, the fund returned +5.4%. Biotech (XBI) returned +19.0% over the same days, so a holder was behind by 13.6 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 60.7%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.

XLSI

Over the year to Nov 4, 2026, XLSI paid 12.5% of its starting value in cash distributions while its price rose 2.7%. With every distribution reinvested, the fund returned +16.3%. State Street Consumer Staples Select Sector SPDR ETF (XLP) returned +24.3% over the same days, so a holder was behind by 8.0 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 10.8%, paid monthly. State Street estimates that 100% of the distribution paid Nov 5, 2026 was a return of capital (its 19a-1 notice).

Questions people ask

Which is cheaper, BIOY or XLSI?
BIOY charges 1.18% a year and XLSI charges 0.35%, so XLSI is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BIOY against XLSI, data as of Nov 4, 2026. https://etfiq.com/compare/income/bioy-vs-xlsi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.